<p id="79lld"><mark id="79lld"></mark></p><address id="79lld"><nobr id="79lld"></nobr></address>
<form id="79lld"></form>

    <form id="79lld"></form>

    <address id="79lld"><form id="79lld"><meter id="79lld"></meter></form></address>
    <form id="79lld"><listing id="79lld"></listing></form>

    We've updated our Privacy Policy to make it clearer how we use your personal data.

    We use cookies to provide you with a better experience, read our Cookie Policy

    Advertisement

    Spanish Flu: A Warning From History

    Video

    To mark the centenary and to highlight vital scientific research, the University of Cambridge made a film exploring what we have learnt about Spanish Flu, the urgent threat posed by influenza today, and how scientists are preparing for future pandemics.

    Watch Now

    PhysioMimix? OOC Lab Benchtop Ready Microphysiological System

    Video

    Despite the complex physiologically relevant 3D biology that it recreates in vitro, our PhysioMimix? OOC Microphysiological System is rather simple to adopt, helping you transition from 2D into 3D cell culture with ease.

    Watch Now

    Spore Formation in Fast Motion - A Yield Strategist and a Synthetic Quality Strategist

    Video

    Natural resources are always limited, so the right strategy decides success. This also applies to spore-forming bacteria. Bacillus subtilis can survive unfavorable living conditions by forming endospores. A time-lapse microscopy study suggests that the bacteria can either make more or better spores, and that natural isolates follow different life cycle strategies.

    Watch Now

    Understanding How Infectious Diseases Spread

    News

    Physicists have used a new model to demonstrate how infection rates decrease through the implementation of social distancing. These models often serve as a basis for political decisions and underline the justification for any measures taken.

    Read more
     
    Interim Analysis Suggests SARS-CoV-2 Vaccine Has 90% Efficacy Rate
    News

    Pharmaceutical company Pfizer and biotechnology company BioNTech have announced the first interim efficacy data from a large-scale trial evaluating BNT162b2, a vaccine candidate developed against SARS-CoV-2. Their press release indicates a vaccine efficacy rate of ~90% seven days after a second dose of the vaccine is administered, however the data is yet to be published.

    Read more

    Method Identifies Llama Nanobodies With "Ultra-High" SARS-CoV-2 Neutralization Potency
    News

    In Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to prevent and treat COVID-19.

    Read more

    Creating Drugs To Inhibit SARS-CoV-2 Entry and Replication Simultaneously
    News

    A research team has reported that compounds simultaneously targeting Mpro and cathepsin L could improve the treatment of COVID-19 infection.

    Read more

     
     
     
    Advertisement
     
    Stay Up-to-Date With COVID-19 Drug Development
    Article

    Whilst the world waits for an effective COVID-19 vaccine to be developed, researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

    Read more

    The Coronavirus Pandemic
    Article

    On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.

    Read more

    The Culture of Cell Culturing: Be Careful Not To Contaminate!
    Article

    Researchers must consider a number of factors for in vitro experiments. Selecting the most appropriate cell line or primary culture for the project at hand is only the first step. Researchers must then be vigilant to prevent contaminating the culture, from the initial moments it is plated and all throughout consecutive passages.

    Read more

    Coronaviruses and Vaccine Design – A Conversation With Jason Kindrachuk
    Article

    Jason Kindrachuk is an assistant professor in the Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Canada. Much of his research is directed towards the circulation, transmission and pathogenesis of emerging viruses that pose significant threats to human and animal health. Technology Networks recently had the pleasure of interviewing Kindrachuk to learn more about his work with coronaviruses and the development of a vaccine candidate against the novel coronavirus, SARS-CoV-2.

    Read more

    New Frontiers in Pharmacokinetics
    Article

    In this article, we look at two factors that may impact the pharmacokinetics of drugs; our gender, and the microbes we share our body with.

    Read more

    Stay Up-to-Date With COVID-19 Vaccine Development
    Article

    Technology Networks is committed to keeping you updated with the latest research in this space. In this article, you'll find a curation of our latest COVID-19 vaccine-related content.

    Read more

     
     
    Advertisement
     
    王中王中特免费公开资料选料